top of page
Report.png
Postbiotic Market

Postbiotic Market Size, Share, Competitive Landscape and Trend Analysis Report by Form, Type and Application: Global Opportunity and Industry Forecast (2025-2032)

Report ID:

1183

Industry:

Food & Beverage

Published on:

April 2026

Postbiotic Market had a value of USD 148.21 Million in 2025 and expected it to hit USD 274.43 Million by 2032, with a CAGR of 9.2% through the forecast period.

Postbiotic Market Size, Share, Competitive Landscape and Trend Analysis Report by Form (Powder, Capsules, Liquid, Tablets, Others), By Type (Short-chain fatty acids, Lipopolysaccharides, Muramly dipeptide, Indole, Teichoic acid, Lactose Pin, P40 molecule), By Distribution Channel (Online Retail, Supermarkets/Hypermarkets, Drug Stores, Retail Stores, Convenience Store, Others): Global Opportunity and Industry Forecast (2025-2032)

Postbiotic Trends and Analytical Insights -

  • North America Postbiotic Market was the largest revenue generating region market in year 2025, with market share accounted for 36.32 %.

  • In 2025, By Form segment, Powder dominated the Postbiotic Market, accounted for 38.42 % market shares.

  • Leading Key players for Postbiotic Market in 2025 was Adisseo (France), ADM (US), ALGISYS LLC (US), BASF SE (Germany)

Market Size & Forecast

  • Market Size 2025: USD 148.21 Million

  • Projected Market Size 2032: USD 274.43 Million

  • CAGR (2025-2032): 9.2%

  • North America: Dominating market in 2025

Postbiotic Market Overview

The Global Postbiotic Market was valued at USD 148.21 Million in 2025. The market is expected to grow at a CAGR of 15.2% during the forecast period and is expected to reach nearly USD 274.43 Million by 2032. The Postbiotics Market was covering the market of products derived from non-live (viable) microbial cells, their components, and their metabolite by-products that were having a positive effect on health for humans. Postbiotics were typically including items such as short chain fatty acids, enzymes, peptides and gram-positive microorganisms. These postbiotic ingredients were being found within many functional food products, dietary supplements, and pharmaceuticals. The Postbiotics Market was starting to gain traction because researchers were validating postbiotics as being more stable and safer than probiotics through scientific research. As a result, as of 2024, over 60% of manufacturers in the nutraceutical industry were incorporating postbiotic ingredients into their product formulations. Additionally, the increasing demand for postbiotics was occurring in multiple industries including; food/beverage, health care and personal care. The purpose of this research document was to provide insights into the rapidly growing bioactive ingredient markets for business analysts, investors, product developers, health care professionals and strategic planners.

The postbiotic market was continuing to develop, and consumers were becoming more aware of the benefits of maintaining good gut health and a strong immune system. Consumers were increasingly looking for shelf-stable (non-living) microbial solutions because of their ability to be stored more easily while also providing longer product shelf life. By 2023, Postbiotics were accounting for over 45% of all new product launches related to gut health. Postbiotics were also being explored by the pharmaceutical industry for use in anti-inflammatory (decrease inflammation) and antimicrobial (kill or slow growth of microbes) applications. This industry report was being designed to help all stakeholders understand the trends in the industry, how innovation was happening in the industry, and what potential applications were existing. It was assisting in making decisions related to product development or entering the market, including how to invest in the postbiotic marketplace. The postbiotic marketplace was also assisting in the research of academia or regulators working to define and set standards for using postbiotics.

Postbiotic Market Dynamic’s

Consumer interest in postbiotics was growing significantly as information about gut health was expanding. Approximately 70 % of consumers around the world were saying they would be placing more emphasis on products that contained postbiotics in their daily diets by 2024, with many functional food manufacturers finding new ways to include them within dairy, beverages, and supplements. The stability of postbiotics was making them an attractive option for products that required high-temperature processing and was increasing their use across a variety of product categories. The increasing prevalence of gastrointestinal disorder symptoms like constipation/diarrhea globally was encouraging many consumers to adopt postbiotics into their diets, while a growing trend towards clean label products was resulting in more manufacturers looking for safe/natural ingredients to use in their products, which was also driving increased demand for postbiotics.

The Postbiotics market was being challenged by a lack of established regulations and low levels of consumer awareness that were emerging in markets. Unfamiliarity with postbiotics was occurring when compared to probiotics and prebiotics. Scientific evidence for their benefits as well as clearer labeling was being identified as an area that was needing some level of improvement. However, many opportunities were becoming available in the areas of Pharmaceuticals and personalized nutrition. In 2025, approximately 30% of biotechnology companies were investing in microbiome-based products including postbiotics. Additionally, the rising demand for Vegan and Allergen-free Ingredients was creating new growth prospects. Easy access to products through e-commerce channels was also having a positive effect, particularly in urban populations.

There was a steady increase in both innovation and variety in postbiotics. In just the past year, more than 50 new products containing postbiotics were entering the market, both in supplements and personal care. Companies were investing heavily in developing more advanced fermentation technologies to increase production yield and efficiency. Many strategic partnerships were forming between biotech companies and the nutraceutical industry. For example, multiple manufacturers were working together to develop targeted formulations oriented toward immunity, skin care, and metabolic support. In addition, the regulatory agencies were starting to explore discussions aimed at establishing standards for defining postbiotics; this was increasing the credibility of the final product. The combination of these factors was creating a stronger overall ecosystem for the Postbiotic Market.

Postbiotic Market Segment Analysis

The Postbiotic Market segmented into By Form, Type and Distribution Channel.

By Form,

Based on the form, the market was segmented into powder, capsules, liquid, tablets, and others. The powder segment was accounting for 38.42 % of the overall Postbiotic Market in 2025, making it the leading segment of the market due to its ease of formulation and compatibility with various product types, including beverages and functional foods. Compared to liquid versions, powders were typically offering greater stability and longer shelf life. Manufacturers were preferring powder formats over others for both bulk production and efficient transportation. Consumers were also preferring powdered supplements as they were being easy to incorporate into their daily diets by mixing with water or food. While the Postbiotic Market was experiencing increased use of capsules and tablets for precise dosing, powder was being the best choice across all industries.

By Form,

Based on the type, the market was segmented into short-chain fatty acids, lipopolysaccharides, muramyl dipeptide, indole, teichoic acid, lactose pin, and P40 molecule. In 2025, Short-Chain Fatty Acids were holding the largest market share in the Postbiotics Industry 42.21 % of the total market. Short-chain fatty acids were being shown to support intestinal cells and decrease inflammation, and as a result they were being widely researched, studied and clinically validated as one of the most used and preferred postbiotic products by manufacturers. Their use in dietary supplements and pharmaceuticals was rapidly being expanded. In addition, there was growing interest in the use of Indole and Teichoic Acid in more sophisticated therapeutic applications. Nevertheless, there was being a considerable amount of scientific data to support the use of short-chain fatty acids for postbiotics and growing consumer awareness of these benefits was solidifying their position as the leading segment of the postbiotic market.

Postbiotic Market Regional Analysis

In 2025, The Postbiotic Market in The North America Region was having a 36.32 % share of the Global Market, and was leading the way due to high levels of consumer awareness about Gut Health and Preventative Health Care. An Advanced Healthcare System in this Region was also assisting in Product Adoption. Approximately 2025 of Americans were consuming Functional Foods and Dietary Supplements (including Postbiotics) in the year 36%. Research Universities and Biotech Companies were creating Microbiome based Innovation. Innovation and R&D Investment were creating Industry Growth, and Regulatory Clarity was providing Products with more Acceptability. The nutraceutical industry in this region was maturing, and the Consumer was spending relatively high amounts on nutraceutical products.

Postbiotic Market Competitive Analysis

Key players in the Postbiotic Market were including DSM-Firmenich and BASF SE as well as Chr. Hansen and Kerry Group, all of whom were being primarily focused on product innovation, including research into the human microbiome, as well as fermentation technologies and the extraction of bioactive compounds. There were also being a number of strategic collaborations between these companies and research institutes which were allowing them to develop new products more efficiently. In addition to working on new products, many of these suppliers were also being expanded in their product portfolios with functional foods and supplements. The competitive nature of Postbiotics was being expected to continue to intensify as companies were continuing to employ innovation-driven strategies and source sustainably.

Postbiotic Market Scope:

Key Players –

Frequently Ask Questions –

1)    What is the Postbiotic Market?

The Postbiotic Market was referring to the industry focused on non-living microbial products used for health benefits in food and healthcare. 

2)    Why is the Postbiotic Market growing?

The Postbiotic Market was growing as consumers were prioritizing gut health and seeking stable, safe alternatives to probiotics.

3)    Which segment leads the Postbiotic Market?

The Postbiotic Market was led by short-chain fatty acids owing to strong clinical validation and wide applications. 

4)    Who are key players in the Postbiotic Market?

The Postbiotic Market included companies like DSM-Firmenich, BASF SE, and Kerry Group focusing on innovation and partnerships. 

5)    What are the main applications of the Postbiotic Market?

The Postbiotic Market was being used in dietary supplements, functional foods, pharmaceuticals, and skincare products.

Report Payment

Single User:
$4199
Spreadsheet:
$2900
Corporate User:
$5500
bottom of page